Taken together, our results unveiled new conceptual and functional avenues in PCa with potential clinical implications, by demonstrating a therapeutic potential of the SST/CORT/SSTRs system and of different SSAs (i.e., octreotide and pasireotide) in AI-PCa cells. This evidence concerns the gene SST and posterior cortical atrophy.